Dr. Colin Franz Receives Development Grant for Research on Activity-Based Treatments to Accelerate Peripheral Axon Regeneration

    5/13/2022
Colin Franz, MD, PhD, was selected to receive a development grant from the ANF in 2021 for his research project “Activity-Based Treatments to Accelerate Peripheral Axon Regeneration.” Franz’s research will set the stage for a follow-up clinical trial to bring the most promising therapy to patients.

Dr. Elie Naddaf Receives Development Grant for Research on the Role of Mitochondria in Inclusion Body Myositis

    4/28/2022
Dr. Naddaf is a neurologist, specializing in NM disease, at the Mayo Clinic in Rochester, Minnesota. Dr. Naddaf’s research objective is to describe the precise nature of mitochondrial dysfunction in IBM. His long-term goal is to identify better diagnostic biomarkers for IBM and novel evidence-based, targetable pathways for clinical trials.

Dr. Yohei Harada Receives Development Grant for Research on Neuromuscular Ultrasound and Electric Impedance Myography in CMT

    4/13/2022
Yohei Harada, MD, was selected to receive a development grant from the ANF in 2021 for his research project “Neuromuscular Ultrasound and Electric Impedance Myography in CMT type 1A:A Prospective Longitudinal Study.”

Dr. Alexander Chamessian Receives ANF Development Grant

    9/8/2020
Alexander Chamessian, MD, PhD, has been selected as a recipient of an American Neuromuscular Foundation Development Grant. Dr. Chamessian’s project is called “Determining the Pathogenicity of Autoantibodies in Idiopathic Small Fiber Neuropathy.” Small fiber neuropathy (SFN) is a group of disorders that involves preferential damage to and dysfunction of small diameter sensory and autonomic nerve fibers.